Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion type Assertion NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_head.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion description "[The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab� used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion evidence source_evidence_literature NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion SIO_000772 21677771 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion wasDerivedFrom befree-2016 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.
- NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_assertion wasGeneratedBy ECO_0000203 NP902453.RAIxlHEi-zPyokLrAi-tOIC91w7cOuBMY7A54NAXgm1V8130_provenance.